A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : AA / androgen ablation

[Related PubMed/MEDLINE]
Total Number of Papers: 14
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   AA  (>> Co-occurring Abbreviation)
Long Form:   androgen ablation
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2013 Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers. AR, Hh
2009 Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization. DC
2009 Implementation of osteoporosis screening guidelines in prostate cancer patients on androgen ablation. BMD
2005 PSA doubling time kinetics during prostate cancer biochemical relapse after external beam radiation therapy. EBRT, PSADT
2004 Androgen ablation adjuvant to postprostatectomy radiotherapy: complication-adjusted number needed to treat analysis. NNT
2004 The effect of combined androgen ablation on the expression of alpha1A-adrenergic receptor in the human prostate. CAD, SMMHC
2003 Changes in prostate-specific antigen and hormone levels following withdrawal of prolonged androgen ablation for prostate cancer. PSA
2003 Evaluation of the Houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time bias. ASTRO, EBRT
2003 Molecular analysis of the androgen receptor in ten prostate cancer specimens obtained before and after androgen ablation. ARs
10  2003 Prostate cancer: advances in immunotherapy. CTLA-4
11  2002 Testosterone recovery following prolonged adjuvant androgen ablation for prostate carcinoma. LHRHa
12  2001 Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma. PSA
13  2000 The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions. ---
14  1998 Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors. CaP, IHC, RT-PCR, SSCP